Showing results (21-30 of 69) with videos related to
Sort By:
Pageof 7
Clinical and Translational Science|November 19, 2024
Integrating real-world data and machine learning: A framework to assess covariate importance in real-world use of alternative intravenous dosing regimens for atezolizumabBianca Vora, Ashutosh Jindal, Erick Velasquez, et al.Journal of Lipid Research|April 27, 2017
An in silico model of retinal cholesterol dynamics (RCD model): insights into the pathophysiology of dry AMDSeyedeh Maryam Zekavat, James Lu, Cyrille Maugeais, et al.Pharmaceutics|May 27, 2023
Machine Learning for Exposure-Response Analysis: Methodological Considerations and Confirmation of Their Importance via Computational ExperimentationsRashed Harun, Eric Yang, Nastya Kassir, et al.BMC Methods|May 20, 2026
Optimizing post-transplantation detection of subcutaneously transplanted islets using dithizone stainingJames Lu, Matthew Ishahak, Marlie M Maestas, et al.Genome Research|January 9, 2013
An integrative variant analysis pipeline for accurate genotype/haplotype inference in population NGS dataYi Wang, James Lu, Jin Yu, et al.American Journal of Physiology. Endocrinology and Metabolism|May 2, 2003
Expression of uncoupling protein 3 is upregulated in skeletal muscle during sepsisXiaoyan Sun, Curtis Wray, Xintian Tian, et al.Plos Computational Biology|July 24, 2020
An in vitro quantitative systems pharmacology approach for deconvolving mechanisms of drug-induced, multilineage cytopeniasJennifer L Wilson, Dan Lu, Nick Corr, et al.Biorxiv : the Preprint Server for Biology|February 17, 2023
Paracrine enhancement of tumor cell proliferation provides indirect stroma-mediated chemoresistance via acceleration of tumor recovery between chemotherapy cyclesDaria Miroshnychenko, Tatiana Miti, Pragya Kumar, et al.Cancer Research|October 4, 2023
Stroma-Mediated Breast Cancer Cell Proliferation Indirectly Drives Chemoresistance by Accelerating Tumor Recovery between Chemotherapy CyclesDaria Miroshnychenko, Tatiana Miti, Pragya Kumar, et al.CPT: Pharmacometrics & Systems Pharmacology|October 4, 2022
Applying interpretable machine learning workflow to evaluate exposure-response relationships for large-molecule oncology drugsGengbo Liu, James Lu, Hong Seo Lim, et al.Pageof 7